The March 2025 quarter revenue stood at Rs. 9660.80 millions, up 6.06% as compared to Rs. 9108.70 millions during the corresponding quarter last year.A comparatively good net profit growth of 34.73% to Rs. 2601.40 millions was reported for the quarter ended March 2025 compared to Rs. 1930.80 millions of previous same quarter.Operating Profit saw a handsome growth to 3702.00 millions from 2851.80 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 9660.80 9108.70 6.06 37234.90 34072.50 9.28 37234.90 34072.50 9.28
Other Income 394.60 298.70 32.11 1425.60 1234.80 15.45 1425.60 1234.80 15.45
PBIDT 3702.00 2851.80 29.81 13118.50 10241.30 28.09 13118.50 10241.30 28.09
Interest 5.80 7.70 -24.68 13.10 18.00 -27.22 13.10 18.00 -27.22
PBDT 3696.20 2868.10 28.87 13152.30 8787.20 49.68 13152.30 8787.20 49.68
Depreciation 147.20 181.00 -18.67 667.90 696.80 -4.15 667.90 696.80 -4.15
PBT 3549.00 2687.10 32.08 12484.40 8090.40 54.31 12484.40 8090.40 54.31
TAX 947.60 756.30 25.29 3293.80 2243.50 46.82 3293.80 2243.50 46.82
Deferred Tax 54.20 144.70 -62.54 62.00 -113.60 -154.58 62.00 -113.60 -154.58
PAT 2601.40 1930.80 34.73 9190.60 5846.90 57.19 9190.60 5846.90 57.19
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 38.32 31.31 22.39 35.23 30.06 17.21 35.23 30.06 17.21

Glaxosmithkline Phar Share Price

2463.95 -19.40 (-0.78%)
05-Jan-2026 11:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1742.35
Dr. Reddys Lab 1255.00
Cipla 1520.20
Zydus Lifesciences 920.60
Lupin 2100.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×